1. The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients
    Hyunkyung Park et al, 2022, Leukemia Research CrossRef
  2. Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
    Amir Imran Faisal Hamdi et al, 2022, Expert Review of Anticancer Therapy CrossRef
  3. Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase
    Shyam A. Patel et al, 2021, JCO Precision Oncology CrossRef
  4. The Impact of SKP2 Gene Expression in Chronic Myeloid Leukemia
    Hossam Hodeib et al, 2022, Genes CrossRef
  5. A review of the therapeutic role of the new third-generation TKI olverembatinib in chronic myeloid leukemia
    Honglan Qian et al, 2022, Frontiers in Oncology CrossRef
  6. Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
    Arti Easwar et al, 2021, Life CrossRef
  7. FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial
    E Dianne Pulte et al, 2022, The Oncologist CrossRef